Back to Journals » Drug Design, Development and Therapy » Volume 13

Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura

Total article views   HTML views PDF downloads Totals
18,133 Dovepress* 13,394+ 1,676 15,070
PubMed Central* 4,739 1,199 5,938
Totals 18,133 2,875 21,008
*Since 17 April 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar